Session Details
The Impact of Psychoneuroimmunology for Therapeutic Progress: Part 1
Tuesday, 10 February 2004 14:30 -16:00
Harbourside Meeting Room 3
Chairperson
Michael Maes
The Netherlands
Cytokines, prostaglandins and depression: Impact for therapeutic advances?
Brian E Leonard, National University of Ireland, Ireland
Immuno-genetic and immuno-phenotypic gender differences in schizophrenia
Markus J Schwarz, Psychiatric Hospital, University of Munich, Germany
TNF-alpha, depression and autoimmunity
Dr Olya Mikova, University Hospital of Neurology and Psychiatry "St Naum", Bulgaria